These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 8016510)

  • 1. [Erythropoietin: from gene to therapeutic agent].
    Bauer C
    Schweiz Rundsch Med Prax; 1994 Jun; 83(23):698-701. PubMed ID: 8016510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biology of erythropoietin.
    Jelkmann W
    Clin Investig; 1994; 72(6 Suppl):S3-10. PubMed ID: 7950169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Erythropoietin--from gene structure to therapeutic applications.
    Bauer C
    J Perinat Med; 1995; 23(1-2):77-81. PubMed ID: 7658325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Erythropoietin: biological aspects and clinical usefulness.
    Liberato NL; Costa A; Barosi G
    Haematologica; 1990; 75(4):346-62. PubMed ID: 2276680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Overview of erythropoietin].
    Lacombe C; Mayeux P; Casadevall N
    Nephrologie; 1991; 12(5):221-6. PubMed ID: 1662784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Erythropoietin: its biological properties and clinical use].
    Ermolenko VM; Nikolaev AIu
    Ter Arkh; 1990; 62(11):141-5. PubMed ID: 2094979
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of erythropoietin treatment on O2 affinity and performance in patients with renal anemia.
    Böcker A; Reimers E; Nonnast-Daniel B; Kühn K; Koch KM; Scigalla P; Braumann KM; Brunkhorst R; Böning D
    Contrib Nephrol; 1988; 66():165-75. PubMed ID: 3391031
    [No Abstract]   [Full Text] [Related]  

  • 8. Erythropoietin.
    Erslev AJ
    Leuk Res; 1990; 14(8):683-8. PubMed ID: 2201820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Human recombinant erythropoietin: from clinical aspects to the physiopathology of anemia of renal insufficiency].
    Wauters JP
    Rev Med Suisse Romande; 1990 Nov; 110(11):951-4. PubMed ID: 2267466
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of chronic renal failure on the expression of erythropoietin message in a murine model.
    Zhang F; Laneuville P; Gagnon RF; Morin B; Brox AG
    Exp Hematol; 1996 Nov; 24(13):1469-74. PubMed ID: 8950229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of recombinant human erythropoietin for management of anemia in dogs and cats with renal failure.
    Cowgill LD; James KM; Levy JK; Browne JK; Miller A; Lobingier RT; Egrie JC
    J Am Vet Med Assoc; 1998 Feb; 212(4):521-8. PubMed ID: 9491159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resistance to recombinant human erythropoietin therapy in a child with renal failure due to primary hyperoxaluria type 1.
    Lavoratti GC; Seracini D; Pela I; Materassi M; Vichi GF; Di Lollo S; Bartolozzi G
    Nephrol Dial Transplant; 1994; 9(11):1645-8. PubMed ID: 7870357
    [No Abstract]   [Full Text] [Related]  

  • 13. Erythropoietin therapy in renal failure.
    Paganini EP; Miller T
    Adv Intern Med; 1993; 38():223-43. PubMed ID: 8438638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Assessment of the erythropoietin-producing function of the kidney and liver under controlled perfusion].
    Nefedov VP; Makarov VP; Tashenov EK; Krizhanovskaia EV; Kazakov VN
    Biull Eksp Biol Med; 1986 Oct; 102(10):404-6. PubMed ID: 3768502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathogenesis of renal anemia.
    Nangaku M; Eckardt KU
    Semin Nephrol; 2006 Jul; 26(4):261-8. PubMed ID: 16949463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erythropoietin-- measurement and clinical applications.
    Marsden JT
    Ann Clin Biochem; 2006 Mar; 43(Pt 2):97-104. PubMed ID: 16536911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Erythropoietin, the biology of erythropoiesis and epoetin alfa. An overview.
    Bieber E
    J Reprod Med; 2001 May; 46(5 Suppl):521-30. PubMed ID: 11396386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liver to kidney switch of erythropoietin formation.
    Zanjani ED
    Exp Hematol; 1980; 8 Suppl 8():29-40. PubMed ID: 7349641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Individual differences in the efficacy of Recormon in patients with terminal kidney failure. The role of iron deficiency].
    Nikolaev AIu; Klepikov PV; Lashutin SV; Kondakhchan MA; Rogov VA; Trofimova EI
    Ter Arkh; 1993; 65(6):45-8. PubMed ID: 8378849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant erythropoietin.
    Spivak JL
    Annu Rev Med; 1993; 44():243-53. PubMed ID: 8476246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.